Webinar: How to profit from recent innovations in small molecule drug discovery
The webinar, led by Dotmatics’ Director of Product Marketing Haydn Boehm on September 29 at 14:00 BST, will explore the resurgence and innovation in small molecule drug discovery, addressing current research landscapes, challenges, and strategies for optimizing data integration and workflows to accelerate drug candidate identification and reduce costs.
With small molecules making up over 60% of new drug approvals in 2021, the appetite for progression and potential for innovation in this area is significant. The resurgence of small molecule drug discovery signals a renewed focus on exploring uncharted biologically active chemical space.
During this one-hour webinar with Dotmatics’ Director of Product Marketing, Haydn Boehm, the following topics will be explored:
- The current landscape of small and large molecule research
- Friction points scientists may encounter in the small molecule drug discovery process
By attending this webinar, you will learn:
- Why research collaboration is vitally important for all scientists working in this field
- How to get the most out of data from multiple sources by efficiently merging and managing all available data, regardless of its origin
- How to optimize your workflow according to your specific needs, ultimately improving cycle times, reducing costs, and finding better candidates as quickly as possible
Featured Speaker
Haydn Boehm
Haydn Boehm is focused on helping the life science and drug discovery industries harmonize their science and data, accelerating innovation to make the world a healthier, cleaner, and better place. He has 20 years of sales and marketing leadership experience in the life science industry, having worked with companies such as ThermoFisher Scientific, Johnson Matthey, and Merck KGaA’s Connected Lab Program. Haydn holds a PhD in Organic Chemistry from the University of Nottingham, UK, and lives on the Jurassic Coast in Devon, UK with his family.
Event Details
- Date: September 29
- Time: 14:00 BST
- Location: Online
Related
Webinar: The New Era of Small Molecule Drug Discovery
The webinar on August 18 at 4pm BST/11am EDT, featuring Haydn Boehm—an experienced organic chemist and life science industry leader—will address the challenges in small molecule drug discovery and demonstrate strategies to reduce risks, costs, and time to accelerate therapeutic breakthroughs.
Our 11 Most-Read Blogs of 2023: AI, Biologics, ELNs, and More
Dotmatics' top blogs of 2023 highlight key scientific advancements including the convergence of small molecule and biologic drug development, the integration and comparison of LIMS and ELN systems for enhanced lab data management, and strategies to minimize human errors in biologics research through automation and calibration.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
Webinar: Are you Ready for the Renaissance in Small Molecule Drug Discovery?
The webinar titled "Are you Ready for the Renaissance in Small Molecule Drug Discovery?" scheduled for February 2, 2023, features expert Haydn Boehm discussing challenges in small molecule drug discovery, emphasizing the importance of research collaboration, efficient data integration from multiple sources, and workflow optimization to reduce costs and accelerate finding better therapeutic candidates.
Data Management, Collaboration, and Workflow Optimisation: The Three Keys to Small Molecule Discovery Success
The article emphasizes that despite biologics' prominence, small molecule drug discovery is experiencing a renaissance driven by advances in screening, target exploration, and AI, but overcoming challenges like rising costs, data management, fragmented workflows, and CRO reliance requires success in three key areas: next-generation data management, enhanced cross-disciplinary research collaboration, and workflow optimization.
Chem-Bio Informatics Society (CBI) Annual Meeting 2022
At the Chem-Bio Informatics Society (CBI) Annual Meeting 2022 held on October 25 at Tower Hall Funabori in Tokyo, Dotmatics will present and exhibit their advanced integrated platform that enhances collaboration and automates data handling across diverse chemical and biological modalities to support multimodality drug discovery research, with speakers Zsolt Lepp and Takashi Fukuyama showcasing real-world solutions at booth number 4.